KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Equity Income (2016 - 2025)

Cme (CME) has disclosed Equity Income for 17 consecutive years, with $88.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Equity Income fell 3.29% to $88.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $371.7 million, a 5.93% increase, with the full-year FY2025 number at $371.7 million, up 5.93% from a year prior.
  • Equity Income was $88.2 million for Q4 2025 at Cme, down from $96.3 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $99.0 million in Q2 2025 to a low of $55.7 million in Q2 2021.
  • A 5-year average of $78.3 million and a median of $77.5 million in 2023 define the central range for Equity Income.
  • Peak YoY movement for Equity Income: surged 56.73% in 2022, then fell 13.97% in 2023.
  • Cme's Equity Income stood at $67.5 million in 2021, then fell by 5.19% to $64.0 million in 2022, then rose by 4.38% to $66.8 million in 2023, then surged by 36.53% to $91.2 million in 2024, then fell by 3.29% to $88.2 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Equity Income are $88.2 million (Q4 2025), $96.3 million (Q3 2025), and $99.0 million (Q2 2025).